InvestorsHub Logo
Post# of 176695
Next 10
Followers 7
Posts 758
Boards Moderated 0
Alias Born 10/11/2018

Re: None

Tuesday, 10/23/2018 3:06:05 PM

Tuesday, October 23, 2018 3:06:05 PM

Post# of 176695
BEST STOCK IDEA
*US-based late-stage medical device healthcare company preparing for final FDA submission of its groundbreaking product. Human trial approval will be imminent!

* Brachytherapy (internal radiotherapy) devices for cancer treatment an industry projected to grow 250% from 2013 - 2030 with very few players.
Patented brachytherapy cancer product - Yttrium-90 RadioGel™ which is anticipated to be used as the front-line therapy for any cancerous tumor that cannot be removed by surgery;

*RadioGel is a revolutionary product developed by a team of world-class scientists with decorated backgrounds, which is a radioactive polymer is injected into any tumor then hardens to prevent any radioactivity from spreading around the body.

*The radioactive isotope RDGL uses, Y-90 produces a strong therapeutic dose that focuses its killing power to the tumor which could make traditional radiation methods obsolete, and have RDGL capture a significant portion of the projected $2.4B market.

Tiny $10 million market value of company: stock is trading at less than 2 penny per share! it can be over 100 M or 1000M soon, but do your own DD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News